Buch, Englisch, 437 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 769 g
Reihe: Contemporary Cardiology
Acute and Long-Term Impacts
Buch, Englisch, 437 Seiten, Paperback, Format (B × H): 155 mm x 235 mm, Gewicht: 769 g
Reihe: Contemporary Cardiology
ISBN: 978-3-031-15480-5
Verlag: Springer International Publishing
Chapters provide the reader with a contemporary perspective on the emerging links between COVID-19 and cardiovascular disease. In addition, this volume discusses the clinical implications and therapeutic goals in patients with COVID-19 and cardiac complications, as well as possible therapeutic options. It also offers clear recommendations on how to manage (both non- and pharmacologically) to avoid the increased number of COVID-19 related deaths due to CVD and its risk factors.
Cardiovascular Complications of COVID-19 will be the primary resource for physicians, residents, fellows, and nursed and medical students in the fields of cardiology and COVID-19/infectious diseases as well as healthcare providers that initiate preventive activities and dedicated programs.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Part I: Introduction.- Biology of SARS-CoV-2 coronavirus; origin, structure, and variants.- Epidemiology of COVID-19.- Clinical symptoms and course of COVID-19.- Risk factors of developing COVID-19 and its severe course.- Prognosis in COVID-19 patients - statistics, risk factors.- Part II: Cardiovascular Implications of the Acute Phase of COVID-19.- Myocardial injury in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment).- Acute coronary syndrome – destabilization of atherosclerotic plaque in COVID-19 (epidemiology, influence on prognosis, pathogen-esis and treatment).- Acute Vascular Injury in COVID-19.- Heart failure and acute circulatory failure in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment) .- Cardiomyopathy in COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment).- Arrhythmias in COVID-19.- Thromboembolic events in COVID-19 .- Stroke in COVID-19.- Pulmonary embolism after COVID-19 (epidemiology, influence on prognosis, pathogenesis, treatment).- Interaction of anti-COVID-19 drugs with cardiovascular therapy.- Part III: Influence of the Treatment of Cardiovascular Diseases on the Course of COVID-19.- Beyond the vaccines-Bioactive lipids in COVID-19.- Statins and COVID-19 (mechanism of action, effect on prognosis).- Covid-19 And Antihypertensive Treatment.- Colchicine in COVID-19 (mechanism of action, effect on prognosis).- Antiplatelet drugs in COVID-19: mechanism of action and effect on prognosis.- Antidiabetic drugs in COVID-19.- Part IV: Cardiovascular Complications of Long-COVID-19.- Long COVID-19 - Definition, Epidemiology, and Clinical Implications.- Cardiovascular complications of long COVID-19 - prevalence, diagnosis and risk factors.- Cardiovascular complications of Long-COVID – management.- Part V The impact of COVID-19 pandemic on the e-services and digital tools development in medicine.- The impact of the COVID-19 pandemic on e-services and digital tools development in medicine.